Depixus

About:

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

Twitter/X: depixus

Top Investors: Bpifrance, AGORANOV, Casdin Capital, EASME - EU Executive Agency for SMEs, Lansdowne Partners

Description:

Depixus includes a Full genome analysis, which necessitates technologies capable of reading DNA, RNA, and their base changes. The dynamics of this cannot be captured with single-molecule precision by today's sequencing technology.

Total Funding Amount:

33.6M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2012-01-01

Contact Email:

info(AT)depixus.com

Founders:

Gordon Hamilton

Number of Employees:

51-100

Last Funding Date:

2021-12-15

IPO Status:

Private

Industries: